Virtual Radiologic Corp. (NASDAQ: VRAD), a leading provider of
virtual radiology services and technology solutions, today reported
financial results for its fourth quarter and full year ended
December 31, 2009.
Full Year Financial
Highlights
- Read volume up 21% to 2.7
million
- Revenue up 13% to $120.7
million
- Adjusted EBITDA(1) up 34% to
$27.6 million and 23% of revenue
- Adjusted net income(2) up 31% to
$12.7 million; adjusted diluted earnings per share(3) (EPS) up 37%
to $0.78
- GAAP net income of $7.9 million;
GAAP diluted EPS of $0.48
- Cash of $50.2 million, up from
cash and short-term investments of $29.3 million at December 31,
2008; the Company has no debt
Fourth Quarter Financial
Highlights
- Read volume up 16% to
687,000
- Revenue up 6% to $29.9
million
- Adjusted EBITDA(1) up 16% to
$5.8 million and 19% of revenue
- Adjusted net income(2) up 18% to
$2.4 million; adjusted diluted earnings per share(3) (EPS) up 25%
to $0.15
- GAAP net income of $1.1 million;
GAAP diluted EPS of $0.07
Additional Fourth Quarter
Highlights
- Finals volume grew 47%,
representing 32% of total volume
- Ranked #1 in Teleradiology
Services by KLAS for second consecutive year
- Released vRad Enterprise Connect
2.1, providing radiology practices with added productivity and
growth tools
- Named to Deloitte’s 2009
Technology Fast 500™
- Completed deployment of
proprietary vRad PACS to all of its 143 affiliated
radiologists
“We are pleased with our full year financial performance despite
the challenging economic environment that existed throughout 2009,”
said Rob Kill, Virtual Radiologic’s president and chief executive
officer. “We believe we have positioned Virtual Radiologic to
continue as the innovative growth leader in the virtual radiology
arena.”
Fourth Quarter and Full Year
Results
Total revenue increased 6% to $29.9 million and 13% to
$120.7 million for the three and twelve months ended December 31,
2009, compared to $28.3 million and $106.6 million for the three
and twelve months ended December 31, 2008. The increase in revenue
over the fourth quarter and full year of 2008 resulted primarily
from a 14% year-over-year increase in the number of hospitals and
medical facilities served to 1,173 as of December 31, 2009,
representing approximately 19% of all hospitals in the United
States.
Adjusted EBITDA increased 16% to $5.8 million and 34% to
$27.6 million for the three and twelve months ended December 31,
2009, compared to $5.0 million and $20.5 million for the three and
twelve months ended December 31, 2008. Adjusted EBITDA was 19% and
23% of revenue for the three and twelve months ended December 31,
2009 compared to 18% and 19% for the prior year periods.
Adjusted net income increased 18% to $2.4 million and 31%
to $12.7 million for the three and twelve months ended December 31,
2009, compared to $2.0 million and $9.7 million for the three and
twelve months ended December 31, 2008. This resulted in an adjusted
diluted EPS of $0.15 and $0.78 for the three and twelve months
ended December 31, 2009, compared to $0.12 and $0.57 for the three
and twelve months ended December 31, 2008.
GAAP net income was $1.1 million and $7.9 million for the
three and twelve months ended December 31, 2009, compared to
$890,000 and $8.5 million for the three and twelve months ended
December 31, 2008, resulting in diluted earnings per share of $0.07
and $0.48 for the three and twelve months ended December 31, 2009,
compared to $0.05 and $0.50 for the three and twelve months ended
December 31, 2008, respectively.
2010 Guidance
The Company is providing the following guidance for the full
year of 2010:
- Revenue ranging from $127.0
million to $131.0 million
- Adjusted EBITDA ranging from
$28.0 million to $30.0 million
- Adjusted net income ranging from
$12.6 million to $13.8 million
- Adjusted diluted earnings per
share ranging from $0.75 to $0.82
Conference Call Information
The Company will be hosting a conference call January 25, 2010
at 4:30 p.m. Eastern Time to discuss these results and provide a
general business update. Participants can access the call by
dialing (800) 561-2693 (within the United States and Canada), or
(617) 614-3523 (outside the United States and Canada), using
passcode 78354286. A live webcast of the conference call will be
available on the Company’s corporate web site at
http://ir.virtualrad.com under “Calendar of Events.” A replay of
the call will be available from 7:30 p.m. Eastern Time on Monday,
January 25, 2010, through midnight on Monday, February 1, 2010.
Access the replay by dialing (888) 286-8010 or (617) 801-6888,
using passcode 62331925.
About Virtual Radiologic
Virtual Radiologic Corporation (vRad) is a national radiology
practice working in partnership with radiologists and hospitals to
optimize radiology’s pivotal role in the delivery of patient
care. Enabled by next-generation technology, vRad’s
collaborative partnerships enhance productivity and deliver
demonstrated quality outcomes that help lower the overall cost of
care. vRad’s 143 affiliated radiologists serve 1,170
facilities (nearly 20% of U.S. hospitals), reading more than 2.6
million interpretations annually with unparalleled subspecialist
expertise and expedited time to diagnosis. Continually recognized
for high-quality reports and industry-leading service, vRad is
ranked #1 in the teleradiology services category by independent
healthcare research firm KLAS and has received the Joint Commission
Gold Seal of Approval each year since 2004. For more
information, visit www.vrad.com.
Safe Harbor for Forward-Looking and Cautionary
Statements
Certain statements in this press release are "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934,
including, in particular, statements about plans, objectives,
strategies and prospects regarding, among other things, vRad’s
business and results of operations. These statements can be
identified by the use of words such as “will,” “believe,” “expect,”
and “anticipate” and similar terms or expressions of future
expectation. These statements involve a number of risks,
uncertainties and other factors that could cause actual results,
performance or achievements of vRad to be materially different from
any future results, performance or achievements expressed or
implied by these forward-looking statements. For examples of such
risks and uncertainties, please see vRad’s Annual Report on Form
10-K, as well as other filings with the Securities and Exchange
Commission. vRad undertakes no duty to update these forward-looking
statements due to new information or as a result of future
events.
Notes Regarding the Use of Non-GAAP Financial
Measures
vRad records its results of operations in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”). In addition, vRad is providing certain
supplemental non-GAAP information which the Company believes to be
an important indicator of its financial performance. vRad uses the
following non-GAAP financial measures:
- Adjusted EBITDA – net income
excluding the net effects of interest, income taxes, depreciation
and amortization, non-cash stock-based compensation expense and
medical malpractice loss reserves (other than specific case
reserves);
- Adjusted net income – net income
excluding the effects of non-cash stock-based compensation, net of
tax, and medical malpractice loss reserves (other than specific
case reserves), net of tax; and
- Adjusted diluted earnings per
share – adjusted net income divided by weighted average diluted
shares outstanding.
vRad presents these non-GAAP financial measures because it
believes that they are a useful indicator of its performance and
on-going operations. The Company believes that these non-GAAP
financial measures are useful to investors in part because such
measures are frequently used by securities analysts to measure a
company’s operating performance without regard to certain items,
such as income tax expense, net interest income and depreciation
and amortization, which can vary substantially from company to
company. vRad’s management also uses these non-GAAP financial
measures in order to review and assess its operating performance
and its management team in connection with certain incentive
programs and the preparation of its financial projections.
Adjusted EBITDA, adjusted net income and adjusted diluted
earnings per share are not measurements of the Company’s financial
performance under GAAP and may not be comparable to the calculation
of similarly titled measures reported by other companies. These
measures should not be considered as an alternative to net income,
earnings per share or any other performance measures derived in
accordance with GAAP.
(1) Adjusted EBITDA consists of net income excluding the net
effects of interest, income taxes, depreciation and amortization,
non-cash stock-based compensation expense and medical malpractice
loss reserves (other than specific case reserves). See “Notes
Regarding the Use of Non-GAAP Financial Measures” and “Supplemental
Information and Non-GAAP Reconciliations” for more information
related to adjusted EBITDA. (2) Adjusted net income consists
of net income excluding the effects of non-cash stock-based
compensation, net of tax, and medical malpractice loss reserves
(other than specific case reserves), net of tax. See “Notes
Regarding the Use of Non-GAAP Financial Measures” and “Supplemental
Information and Non-GAAP Reconciliations” for more information
related to adjusted net income. (3) Adjusted diluted
earnings per share consists of adjusted net income divided by
weighted average diluted shares outstanding. See “Notes Regarding
the Use of Non-GAAP Financial Measures” and “Supplemental
Information and Non-GAAP Reconciliations” for more information
related to adjusted diluted earnings per share.
VIRTUAL RADIOLOGIC CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in thousands, except per share data)
Three Months Ended December 31, Year Ended
December 31, 2009 2008 2009 2008
Revenue $ 29,945 $ 28,301 $ 120,736 $ 106,567
Operating costs and expenses Professional services 15,280 14,187
58,735 49,363 Sales, general and administrative 11,046 11,050
42,317 38,717 Depreciation and amortization 1,871
1,343 6,863 4,700 Total operating costs and
expenses 28,197 26,580 107,915
92,780 Operating income 1,748 1,721 12,821 13,787
Other income (expense) Interest income 63 149 220 599 Interest
expense - - (5 ) - Total other income
63 149 215 599 Income
before income tax expense 1,811 1,870 13,036 14,386 Income
tax expense 726 976 5,143 5,918
Net income 1,085 894 7,893 8,468 Non-controlling interest
expense - 4 - 14 Net
income attributable to Virtual Radiologic $ 1,085 $ 890 $ 7,893
$ 8,454 Earnings per common share Basic $ 0.07
$ 0.06 $ 0.50 $ 0.51 Diluted $ 0.07 $ 0.05 $ 0.48 $ 0.50 Weighted
average common shares outstanding Basic 15,907 15,938 15,872 16,500
Diluted 16,332 16,256 16,283 16,976
SUPPLEMENTAL NON-GAAP
FINANCIAL MEASURES (Unaudited) (in thousands, except
per share data) Three Months Ended December 31,
Year Ended December 31, 2009 2008 2009
2008 Adjusted EBITDA(1) $ 5,799 $ 4,983 $ 27,560 $
20,549 Adjusted net income(1) $ 2,391 $ 2,023 $ 12,662 $ 9,681
Adjusted diluted earnings per share(1) $ 0.15 $ 0.12 $ 0.78 $ 0.57
(1) See “Notes Regarding the Use
of Non-GAAP Financial Measures” and “Supplemental Information and
Non-GAAP Reconciliations” for more information related to the
non-GAAP financial measures presented in this table.
VIRTUAL RADIOLOGIC CORPORATION
SUPPLEMENTAL INFORMATION AND NON-GAAP RECONCILIATIONS
(Unaudited) (in thousands, except per share data)
The following table reconciles the
GAAP financial measure of Net income to the non-GAAP supplemental
financial measure of Adjusted EBITDA which excludes the effects of
interest, income taxes, depreciation and amortization, non-cash
stock-based compensation expense, and medical malpractice loss
reserves (other than specific case reserves). See "Notes Regarding
the Use of Non-GAAP Financial Measures" for more information
related to the non-GAAP financial measures presented in this
table.
Three Months Ended Year Ended December
31, December 31, 2009 2008 2009
2008 Reconciliation of Net income to Adjusted EBITDA:
Net income $ 1,085 $ 894 $ 7,893 $
8,468 Income tax expense 726 976 5,143 5,918 Interest
income, net (63 ) (149 ) (215 ) (599 ) Depreciation and
amortization 1,871 1,343 6,863
4,700 EBITDA 3,619 3,064
19,684 18,487 Physician non-cash
stock-based compensation 134 499 787 (479 ) Employee non-cash
stock-based compensation 585 423 2,420 1,544 Medical malpractice
loss reserves(1) 1,461 997 4,669
997 Adjusted EBITDA $ 5,799 $ 4,983
$ 27,560 $ 20,549 (1) Medical
malpractice loss reserves exclude specific case reserves.
The
following table reconciles the GAAP financial measures of Net
income and Diluted earnings per share to the non-GAAP supplemental
financial measures of Adjusted net income and Adjusted diluted
earnings per share which exclude the effects of non-cash
stock-based compensation expense, net of tax, and medical
malpractice loss reserves (other than specific case reserves), net
of tax. See "Notes Regarding the Use of Non-GAAP Financial
Measures" for more information related to the non-GAAP financial
measures presented in this table.
Three Months Ended Year
Ended December 31, December 31, 2009
2008 2009 2008 Reconciliation of Net
income to Adjusted net income: Net income $ 1,085 $
894 $ 7,893 $ 8,468 Physician non-cash
stock-based compensation, net of tax 80 293 477 (282 ) Employee
non-cash stock-based compensation, net of tax 350 249 1,465 908
Medical malpractice loss reserves, net of tax(1) 876
587 2,827 587 Adjusted
net income $ 2,391 $ 2,023 $ 12,662 $ 9,681
Reconciliation of Diluted earning per share to
Adjusted diluted earnings per share: Diluted earnings per
share $ 0.07 $ 0.05 $ 0.48 $ 0.50
Physician non-cash stock-based compensation, net of tax 0.01 0.02
0.03 (0.02 ) Employee non-cash stock-based compensation, net of tax
0.02 0.01 0.09 0.05 Medical malpractice loss reserves, net of
tax(1) 0.05 0.04 0.18
0.04 Adjusted diluted earnings per share $ 0.15
$ 0.12 $ 0.78 $ 0.57 Weighted
average diluted shares outstanding 16,332 16,256 16,283 16,976
(1) Medical malpractice loss reserves exclude specific case
reserves.
VIRTUAL RADIOLOGIC CORPORATION
SUPPLEMENTAL INFORMATION AND NON-GAAP
RECONCILIATIONS - CONTINUED (Unaudited) (in millions,
except per share data)
The following tables reconcile the
non-GAAP financial measures provided in the Company's fiscal year
2010 guidance to their closest comparable GAAP financial measure.
See "Notes Regarding the Use of Non-GAAP Financial Measures" for
more information related to the non-GAAP financial measures
presented in this table.
Year Ended December 31,
2010 Net income $ 6.9 - $ 8.1 Income
tax expense 4.6 - 5.4 Interest income, net (0.2 ) - (0.2 )
Depreciation and amortization 7.3 - 7.3
EBITDA 18.6 - 20.6 Physician non-cash
stock-based compensation 1.2 - 1.2 Employee non-cash stock-based
compensation 2.6 - 2.6 Medical malpractice loss reserves 5.6
- 5.6 Adjusted EBITDA $ 28.0 - $ 30.0
Net income $ 6.9 - $ 8.1
Physician non-cash stock-based compensation, net of tax 0.7 - 0.7
Employee non-cash stock-based compensation, net of tax 1.6 - 1.6
Medical malpractice loss reserves, net of tax 3.4 -
3.4 Adjusted net income $ 12.6 - $ 13.8
Diluted earnings per share $ 0.41 - $ 0.48
Physician non-cash stock-based compensation, net of tax 0.04
- 0.04 Employee non-cash stock-based compensation, net of tax 0.10
- 0.10 Medical malpractice loss reserves, net of tax 0.20
- 0.20 Adjusted diluted earnings per share $
0.75 - $ 0.82 Diluted weighted average shares
outstanding(1) 16.7 (1)Diluted weighted average shares
outstanding for the full year 2010 are calculated using the
treasury stock method in accordance with GAAP based on forecast
assumptions made by the Company.
VIRTUAL
RADIOLOGIC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS AND SELECTED OPERATING
DATA (Unaudited) As of As of
December 31, December 31, 2009 2008
(in thousands) Cash and cash equivalents $ 50,163 $
19,180 Short-term investments - 10,136 Accounts receivable, net
17,384 17,383 Other current assets 4,258 4,826 Other assets
22,396 19,476 Total assets $ 94,201 $
71,001 Current liabilities $ 14,848 $ 11,087 Other
liabilities 10,522 3,397 Total
liabilities 25,370 14,484 Total stockholders' equity 68,831
56,517 Total liabilities and stockholders'
equity $ 94,201 $ 71,001
As of
December 31, 2009 2008 Affiliated
radiologists providing services 143 134 Customers 655 621 Hospitals
and other medical facilities served 1,173 1,026
Three Months Ended Year Ended December
31, December 31, 2009 2008
2009 2008 Total reads 687,298 591,091
2,668,043 2,200,365 Percentage growth over prior year period 16 %
30 % 21 % 30 % Same site volume growth(1) 7 % 2 % 5 % 6 %
Percentage of read revenue from final reads 32 % 27 % 28 % 24 %
(1) Same-site volume growth is calculated as the percentage
increase in the number of reads over the comparable prior year
period generated by a facility that has been under contract for at
least three months at the beginning of the measurement period and
remains a customer throughout that period.
Virtual Radiologic (MM) (NASDAQ:VRAD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Virtual Radiologic (MM) (NASDAQ:VRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024